Capricor Therapeutics is a startup based in the United States, 1 tracked investor.
Capricor Therapeutics is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Capricor Therapeutics is a clinical-stage biotechnology company developing cell- and exosome-based therapies for cardiac and muscular diseases. Its programs have included allogeneic cardiosphere-derived cells and exosome approaches targeting heart repair and Duchenne muscular dystrophy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.